Cardinal Health (CAH) Receives ‘Analyst’ Rating

Cardinal Health (CAH) : 6 brokerage houses believe that Cardinal Health (CAH) is a Strong Buy at current levels. 5 analysts believe that the current prices are in a balance with the stocks fundamentals, hence they propose Hold on Cardinal Health (CAH). Zacks Investment Research suggests a Hold with a rank of 3.The median of all the 11 Wall Street Analysts endorse the stock as a Buy with a rating of 1.91.

Cardinal Health (CAH) : The most positive equity analysts on Cardinal Health (CAH) expects the shares to touch $111, whereas, the least positive believes that the stock will trade at $89 in the short term. The company is covered by 10 Wall Street Brokerage Firms. The average price target for shares are $95.7 with an expected fluctuation of $6.82 from the mean.


Also, Deutsche Bank maintains their rating on the shares of Cardinal Health (NYSE:CAH). The current rating of the shares is Hold. Equity Analysts at the Firm raises the price target to $89 per share from $83 per share. The rating by the firm was issued on August 4, 2016.

Cardinal Health (NYSE:CAH): After opening at $75.1, the stock dipped to an intraday low of $74.41 on Thursday. However, the bulls stepped in to buy at lower levels and pushed the stock higher. The stock touched an intraday high of $76.85 and the buying power remained strong till the end. The stock closed at $76.6 for the day, a gain of 1.78% for the day session. The total traded volume was 4,230,994. The stocks close on the previous trading day was $75.26.

Cardinal Health, Inc. is a healthcare services and products company. The Company operates in two segments: Pharmaceutical and Medical. The Company also provides medical products to patients in the home. In the United States, the Companys Pharmaceutical segment distributes branded and generic pharmaceutical, over-the-counter healthcare and consumer products through its Pharmaceutical Distribution division to retailers, hospitals and other healthcare providers. In China, the Pharmaceutical segment distributes branded, generic and specialty pharmaceutical, over-the-counter healthcare and consumer products, provides logistics, marketing and other services and operates direct-to-patient specialty pharmacies through Cardinal Health China. The Medical segment distributes a range of medical, surgical and laboratory products and provides services to hospitals, ambulatory surgery centers, clinical laboratories and other healthcare providers.

Leave a Reply

Get Pre-Market Alerts!

Get Pre-Market Analysts' Upgrades, Downgrades, Earnings & Initiations with our FREE daily email newsletter.